Geode Capital Management
NPCE icon

Geode Capital Management’s Neuropace NPCE Stock Holding History

Geode Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
666,300
+48,181
+8% +$775K ﹤0.01% 2505
2026
Q1 		$8.13M Buy
618,119
+21,871
+4% +$328K ﹤0.01% 2488
2025
Q4 		$9.21M Buy
596,248
+36,516
+7% +$488K ﹤0.01% 2450
2025
Q3 		$5.77M Buy
559,732
+74,570
+15% +$703K ﹤0.01% 2706
2025
Q2 		$5.41M Buy
485,162
+149,595
+45% +$1.87M ﹤0.01% 2689
2025
Q1 		$4.12M Buy
335,567
+12,594
+4% +$158K ﹤0.01% 2742
2024
Q4 		$3.61M Buy
322,973
+5,781
+2% +$50.3K ﹤0.01% 2901
2024
Q3 		$2.21M Buy
317,192
+25,330
+9% +$185K ﹤0.01% 3088
2024
Q2 		$2.21M Buy
291,862
+174,902
+150% +$1.76M ﹤0.01% 3101
2024
Q1 		$1.54M Buy
116,960
+964
+0.8% +$13.8K ﹤0.01% 3213
2023
Q4 		$1.2M Buy
115,996
+5,787
+5% +$46.2K ﹤0.01% 3286
2023
Q3 		$1.07M Buy
110,209
+38,694
+54% +$227K ﹤0.01% 3287
2023
Q2 		$321K Hold
71,515
– – ﹤0.01% 3827
2023
Q1 		$332K Hold
71,515
– – ﹤0.01% 3811
2022
Q4 		$106K Buy
71,515
+5,945
+9% +$13.2K ﹤0.01% 4378
2022
Q3 		$245K Hold
65,570
– – ﹤0.01% 4087
2022
Q2 		$324K Sell
65,570
-51,298
-44% -$339K ﹤0.01% 3991
2022
Q1 		$959K Sell
116,868
-1,988
-2% -$17.2K ﹤0.01% 3638
2021
Q4 		$1.2M Buy
118,856
+896
+0.8% +$11.6K ﹤0.01% 3628
2021
Q3 		$1.87M Buy
117,960
+6,980
+6% +$147K ﹤0.01% 3376
2021
Q2 		$2.64M Buy
+110,980
New +$2.58M ﹤0.01% 3180

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management's NPCE Position: Q2 2026 in Review

Geode Capital Management increased its Neuropace (NPCE) stake by 7.8% in Q2 2026, buying an estimated $775K and bringing the position to 666,300 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Geode Capital Management first reported a position in NPCE in Q2 2021 and has held it in 21 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Geode Capital Management held 666,300 shares of Neuropace worth $10.6M as of Q2 2026.
  • Geode Capital Management bought 48,181 Neuropace shares in Q2 2026, an estimated $775K.
  • Neuropace made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2505 holding.
  • Geode Capital Management first reported a position in Neuropace in Q2 2021 and has held it in 21 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.